AzTrials
AzTrials

HydrocephalusNCT06629168

The Usage of Telemetric Prechamber Sensor Reservoir in Management of Normal Pressure Hydrocephalus. Comparisson of Benefit for Patients with Implanted Telemetric Prechamber Sensor Reservoir.

An observational study of Hydrocephalus and Normal Pressure Hydrocephalus, run by University Hospital Hradec Kralove at 1 site in Czechia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Normal pressure hydrocephalus (NPH) is a preventable and treatable cause of dementia. However, as a nosological entity, it is significantly underdiagnosed, often being mistakenly classified as presenile or senile dementia without further investigation. Read more about this study

Who is it for?
Ages 40 years and older
What is being tested?
lumbar puncture, External lumbar drainage and Ventriculo-peritoneal shunt placement
Type of treatment
Surgery or procedure
How many people
33 participants
Where
1 siteCzechia
Study dates
1 Jan 2018to 31 Dec 2024
How long will I take part?
1 Year
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients selected based on inclusion criterias, with communicating hydrocephalus

Who may be able to join

  • Patients with diagnosed communicating hydrocephalus
  • mini-mental state examination test > 10 points
  • Absence of any structural lesion on MRI or CT
  • Accepted Informed consent

Who cannot join

  • Non-communicating hydrocephalus
  • Structural lesion on MRI or CT (tumour, contusion, aneurysm)
  • mini-mental state examination test < 10 points
  • Life-expectancy shorter than 1 year
  • Pre-existing other type of dementia (m. Alzheimer, vascular dementia)
  • Surgery lasting more than 120 minutes
  • Blood loss more than 500 ml
  • Adverse events during general anesthesia: mean arterial pressure < 60 mm Hg more than 5 minutes, arrythmia with need for pharmacological treatment

Trial locations and contacts

1 site in 1 country.

Czechia1 site
  • University Hospital Hradec Kralove

    Hradec Králové, 50005

Other trials in Czechia

About this study

Official title: Usage of Telemetric Prechamber Sensor Reservoir in Management of Hydrocephalus

Normal pressure hydrocephalus (NPH) is a preventable and treatable cause of dementia. However, as a nosological entity, it is significantly underdiagnosed, often being mistakenly classified as presenile or senile dementia without further investigation. Ongoing management is crucial, currently relying mainly on indirect methods-clinical and imaging-based. Telemetry offers a real-time, online method to assess actual cerebrospinal fluid pressures, which are crucial for patient management. Telemetry allows for tailoring treatment to the individual patient. This project is planned as a pilot study before a more extensive research project.

Read the detailed description

Normal pressure hydrocephalus (NPH) is a preventable and treatable cause of dementia. However, as a nosological entity, it is significantly underdiagnosed, often being mistakenly classified as presenile or senile dementia without further investigation. Diagnosing NPH is not straightforward; it is based on a series of examinations, the results of which determine whether the patient is a responder and therefore a candidate for shunt surgery (implantation of a ventriculoperitoneal shunt). The medical literature identifies additional criteria that predict whether the implantation of the shunt will have a good or poor effect. However, treatment from a neurosurgical perspective does not end there. Ongoing management is crucial, currently relying mainly on indirect methods-clinical and imaging-based. Telemetry offers a real-time, online method to assess actual cerebrospinal fluid pressures, which are crucial for patient management. Telemetry allows for tailoring treatment to the individual patient. This project is planned as a pilot study before a more extensive research project.

Being tested
lumbar puncture, External lumbar drainage, Ventriculo-peritoneal shunt placement, Follow-up control #1, Follow-up control #2
Keywords
Normal pressure hydrocephalus, VP drainage, telemetry, pressure monitoring
Medical subject headings
Hydrocephalus, Hydrocephalus, Normal Pressure

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • lumbar punctureDiagnostic test

    Standardized lumbar puncture in L3/4 or L4/5 in diagnosis of hydrocephalus and 10-meter-walking test prior and 4 hours after lumbar puncture. Mini-mental state examination is done.

  • External lumbar drainageDiagnostic test

    External lumbar drainage placement for assessing responsivity of external derivation of cerebrospinal fluid. It is test of responsivity to ventriculo-peritoneal shunt placement

  • Ventriculo-peritoneal shunt placementProcedure or surgery

    Surgical procedure based on implantation a thin catheter into brain lateral ventricle (placed through a burrhole from Kocher point) and connection to prechamber and valve (placed behind the ear under skin) and similar thin catheter pushed under skin of neck, chest and abdomen (where put intraperitoneally). Telemetric prechamber placement according the randomization (www.randomization.com) and the envelope method of choosing of patients.

  • Follow-up control #1Diagnostic test

    Patients after VP shunt placement are assesed in gait, general condition and mini-mental state examination score 3 month after surgery. Brain CT control.

  • Follow-up control #2Diagnostic test

    Patients after VP shunt placement are assesed in gait, general condition and mini-mental state examination score 6 month after surgery. Brain CT control.

  • Follow-up control #3Diagnostic test

    Patients after VP shunt placement are assesed in gait, general condition and mini-mental state examination score 9 months after surgery. Brain CT control.

  • Follow-up control #4Diagnostic test

    Patients after VP shunt placement are assesed in gait, general condition and mini-mental state examination score a month after surgery. Brain CT control, 10-meter-walking test, MMSE, self-assessment.

  • Telemetric prechamber readingDiagnostic test

    Non-invasive reading of telemetric prechamber made during each follow-up control.

  • Valve setting changeOther

    Changing of valve setting according patient's actual condition. Decission based on clinical state, radiological finding on CT and values readed from telemetric prechamber. Timing - each follow-up control.

Study groups in NCT06629168
Study groupRoleWhat they receive
Study group "Telemetrics"Patients with diagnosed hydrocephalus undergoing surgery (VP shunt placement) in general anesthesia. During surgery telemetrical prechamber implantad.
Receives: Diagnostic Test: lumbar puncture; Diagnostic Test: External lumbar drainage; Procedure: Ventriculo-peritoneal shunt placement; Diagnostic Test: Follow-up control #1; Diagnostic Test: Follow-up control #2; Diagnostic Test: Follow-up control #3; Diagnostic Test: Follow-up control #4; Diagnostic Test: Telemetric prechamber reading; Other: Valve setting change
Study group "Normal"Patients with diagnosed hydrocephalus undergoing surgery (VP shunt placement) in general anesthesia. During surgery telemetrical prechamber not implantad.
Receives: Diagnostic Test: lumbar puncture; Diagnostic Test: External lumbar drainage; Procedure: Ventriculo-peritoneal shunt placement; Diagnostic Test: Follow-up control #1; Diagnostic Test: Follow-up control #2; Diagnostic Test: Follow-up control #3; Diagnostic Test: Follow-up control #4; Other: Valve setting change

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Comparison of patient's state

    Comparison of mini-mental state examination, gait (measured by 5-meter-walking) test a self-assessment made by patient between both group (telemetric prechamber impanted versus not implanted)

    Measured: 3 month

Secondary outcomes (3)
  1. Comparison in radiological findings

    Comparison of size of brain ventricles on brain CT examination at the end of follow-up between both groups

    Measured: 1 year

  2. Comparison in number of valve setting

    Comparison in number of valve setting between both groups

    Measured: 1 year

  3. Comparison of difference in valve settings

    Comparison of difference in valve settings - between pressure set in time of implantation and at the end of follow up

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Oct 2024
  2. Study start1 Jan 2018
  3. Primary completion31 Oct 2024
  4. Study completion31 Dec 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Other
Enrolment
33 participants (actual)
Target duration
1 Year
IDs, dates and publications
ClinicalTrials.gov ID
NCT06629168
Sponsor's protocol ID
MC00003
Status last verified
Jan 2025
First submitted
3 Oct 2024
Last updated
23 Jan 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Hydrocephalus and Normal Pressure Hydrocephalus, run by University Hospital Hradec Kralove at 1 site in Czechia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Jan 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Czechia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Comparison of patient's state (time frame: 3 month). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Jan 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in